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Cord factor, also called trehalose-6,60-dimycolate
(TDM), is a potent mycobacterial adjuvant. We herein
report that the C-type lectin MCL (also called Clec4d)
is a TDM receptor that is likely to arise from gene
duplication of Mincle (also called Clec4e). Mincle
is known to be an inducible receptor recognizing
TDM, whereas MCL was constitutively expressed in
myeloid cells. To examine the contribution of MCL in
response to TDM adjuvant, we generated MCL-defi-
cientmice. TDMpromoted innate immune responses,
such as granuloma formation, which was severely
impaired in MCL-deficient mice. TDM-induced ac-
quired immune responses, such as experimental
autoimmune encephalomyelitis (EAE), was almost
completely dependent on MCL, but not Mincle.
Furthermore, by generating Clec4egfp reporter mice,
we found that MCLwas also crucial for drivingMincle
induction upon TDM stimulation. These results sug-
gest thatMCL is an FcRg-coupled activating receptor
that mediates the adjuvanticity of TDM.
INTRODUCTION
C-type lectin receptors (CLRs) constitute a large family of carbo-
hydrate binding proteins that is highly conserved in vertebrates
(Zelensky andGready, 2005). CLRs have been recently identified
as pattern recognition receptors (PRRs) for pathogens, similar
to Toll-like receptors (TLRs), RIG-I-like receptors (RLRs), and
NOD-like receptors (NLRs) (Hardison and Brown, 2012; Takeu-
chi and Akira, 2010). Some members of the CLR family utilize
an immunoreceptor tyrosine-based activation motif (ITAM) to
transduce activating signals possessed within their own cyto-1050 Immunity 38, 1050–1062, May 23, 2013 ª2013 Elsevier Inc.plasmic tails, or by coupling with ITAM-bearing signaling
subunits, such as the Fc receptor g (FcRg) chain or DAP12
(Robinson et al., 2006).
We have recently found that the C-type lectin Mincle (macro-
phage inducible C-type lectin, also called Clec4e or Clecsf9)
is an activating receptor that couples with the FcRg chain and
recognizes cord factor, a mycobacterial glycolipid (Ishikawa
et al., 2009; Yamasaki et al., 2008). Cord factor is an immuno-
stimulatory component that elicits pulmonary inflammation
(Bloch, 1950; Yamaguchi et al., 1955). In 1956, the chemical
structure of cord factor was established as trehalose-6,60-
dimycolate (TDM) (Noll et al., 1956). Mincle is an essential
receptor for TDM-induced innate immune responses, such as
granulomagenesis, as well as in vitro macrophage activation
(Ishikawa et al., 2009; Schoenen et al., 2010). TDM induces
the upregulation of Mincle itself (Lee et al., 2012; Schoenen
et al., 2010). However, Mincle is barely detectable in resting cells.
This prompted us to hypothesize that there was an alternative
TDM receptor(s) that might be present in resting cells to drive
the initial expression of Mincle.
MCL (macrophage C-type lectin, also called Clec4d or
Clecsf8) was first cloned as a type II transmembrane C-type
lectin receptor that is expressed in myeloid cells (Arce et al.,
2004; Balch et al., 1998). It has been recently proposed
that MCL acts as an activating receptor (Graham et al., 2012).
However, the signaling subunit and ligand of MCL remains
unidentified. MCL is located on murine chromosome 6 (6F3)
and human chromosome 12 (12p13), in which activating
C-type lectin receptors, including Dectin-1, Dectin-2, and
Mincle, are clustered (Arce et al., 2004; Flornes et al., 2004).
Dectin-1 is a myeloid-specific b-glucan receptor that signals
through a hemITAM within its own cytoplasmic tail (Rogers
et al., 2005). Dectin-2 is associated with FcRg and recognizes
high-mannose oligosaccharides of fungi (Saijo et al., 2010;
Sato et al., 2006). Mincle is also an FcRg-coupled activating re-
ceptor that recognizes pathogens such as fungi or mycobacteria
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Figure 1. Mincle Is Induced by TDM in
Clec4egfp/gfp Mice
(A) Immunoblotting of Mincle in BMDCs. BMDCs
were stimulated with plate-coated TDM for 12 hr.
Lysates were blotted with Mincle antibody (6D6)
and actin antibody.
(B) mRNA expression of Mincle in lungs. Mice were
injected intravenously with oil-in-water emulsion
of TDM. Serial sections of lungs were subjected
to hematoxylin-eosin staining (HE) and in situ
hybridization for MinclemRNA (Mincle). Scale bars
represent 0.5 mm.
(C) Immunoblotting of Mincle in lungs. Lysates of
lungs from TDM-injected mice were blotted with
Mincle antibody (6D6) and actin antibody.
(D) GFP induction in Clec4e+/gfp mice upon TDM
stimulation. Clec4e+/+ and Clec4e+/gfp mice were
injected intravenously with TDM. GFP+ cells in
lungs were analyzed by flow cytometry.
(E) GFP expression in Clec4egfp/gfp mice.
Clec4e+/gfp and Clec4egfp/gfp mice were injected
with TDM. At day 3, whole lung cells were stained
with CD11b antibody and analyzed by flow cy-
tometry. Numbers in quadrants indicate percent-
age of CD11b+GFP+ cells.
(F) GFP expression in Clec4egfp/gfp 3 Fcer1g/–
mice. Clec4e+/gfp 3 Fcer1g/– and Clec4egfp/gfp 3
Fcer1g/– mice were injected with TDM.
(G) Mincle antibody 1B6 blocks GFP induction in
Clec4egfp/gfp mice. Mice were injected intrave-
nously with 500 mg of Mincle antibody 1B6 at
30 min before TDM injection. Right, percentage of
GFP+ cells. **p < 0.01.
Data are presented as mean ± SD (D, G) and are
representative of two (B, C, E–G) or three (A, D)
separate experiments. See also Figure S1.
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MCL Is an FcRg-Coupled TDM Receptor(Ishikawa et al., 2009; Schoenen et al., 2010; Wells et al., 2008;
Yamasaki et al., 2008, 2009). These recent observations raise
the possibility that MCL may also function as a PRR for
pathogens.
In this study, we report that MCL is an FcRg-coupled acti-
vating receptor that recognizes mycobacterial cord factor.
MCL is constitutively expressed in myeloid cells and drives
inducible Mincle expression upon stimulation by cord factor.
Moreover, cord factor failed to induce innate and acquired
immunity in MCL-deficient mice.Immunity 38, 1050–10RESULTS
Mincle Is Induced by TDM in the
Absence of Mincle Protein
Mincle is an essential receptor for TDM
(Ishikawa et al., 2009; Schoenen et al.,
2010). TDM stimulation induced Mincle
expression in bone-marrow-derived den-
dritic cells (BMDCs) (Figure 1A), thus
suggesting that an autoamplification
loop of Mincle may operate through
Mincle-mediated signaling. Furthermore,
in vivo injection of TDM dramatically
induced Mincle expression in the lungs,
which overlapped with the granulomaarea (Figure 1B). The induction ofMincle protein was also evident
by an immunoblot analysis (Figure 1C). However, Mincle expres-
sion was barely detected under resting (unstimulated) conditions
(Figures 1A–1C), which prompted us to hypothesize that another
TDM receptor, rather than Mincle itself, may promote the initial
induction of Mincle.
In order to determine which receptor is responsible for this
initial induction, we established green fluorescent protein (GFP)
reporter mice that enabled us to monitor Mincle expression in
the absence of Mincle protein by inserting a GFP gene into the62, May 23, 2013 ª2013 Elsevier Inc. 1051
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Figure 2. Identification of a C-type Lectin
MCL as a TDM Receptor
(A) mRNA expression of genes containing 1B6-
epitope sequence. Genes containing VEGQW
sequence according to NCBI protein BLAST
database except for Mincle. mRNA expression of
these genes in lungs was detected by RT-PCR.
(B) Schematic representations of Mincle and MCL.
TM, transmembrane.
(C) Binding of 1B6 to MCL. hIgG1-Fc (Ig) andMCL-
Ig were incubated with biotinylated 1B6. 1B6
binding to Ig-fusion protein was measured as
luminescence induced by energy transfer as
described in Experimental Procedures.
(D) MCL binds to TDM. Ig, Mincle-Ig, and MCL-Ig
were incubated with 0.2 mg/well plate-coated
TDM. Bound proteins were detected with anti-
hIgG-HRP.
(E) mRNA expression of Mincle and MCL. RT-PCR
was performed with mRNA from BMDMs and
BMDCs.
(F and G) Expression of Mincle and MCL upon
stimulation. BMDCs were stimulated with TDM for
indicated periods and the expression amount of
mRNA (F) and protein (G) were determined.
Data are presented as mean ± SD (C–F) and are
representative of two (A, C, G) or three (D–F)
separate experiments. See also Figure S2.
Immunity
MCL Is an FcRg-Coupled TDM ReceptorMincle genomic locus (Clec4egfp/gfp) (Figure S1 available online).
BMDCs from Mincle-sufficient heterozygous (Clec4e+/gfp) mice
showed induced expression of GFP as well as Mincle upon stim-
ulation, suggesting that GFP from the Clec4egfp allele faithfully
reflected Mincle expression (Figure S1D). Clec4egfp/gfp BMDCs
lost the expression of the Mincle protein, as expected. Mean-
while, TDM injection into Clec4e+/gfp mice increased GFP
expression in pulmonary CD11b+ cells (Figures 1D and 1E,
top). GFP was also induced by TDM even in Mincle-deficient
Clec4egfp/gfp mice, albeit to a lesser extent (Figure 1E, bottom).
This implies that ligand-induced Mincle expression could be
initiated by a receptor(s) other than Mincle. The GFP expression
in Clec4egfp/gfp mice was totally abolished when they were
crossed with Fcer1g/– mice, suggesting that FcRg is required
for the ‘‘Mincle-independent’’ receptor signaling (Figure 1F).
GFP induction was inhibited by a Mincle antibody (1B6) even in
the absence of Mincle (Clec4egfp/gfp) (Figure 1G, bottom). These
results raised the possibility that a molecule that cross-reacts
with the mAb (1B6) may act as a TDM receptor through FcRg.
MCL Is a TDM Receptor
Wehave previously identified the epitope sequence of theMincle
antibody 1B6 as a valine-glutamic acid-glycine-glutamine-tryp-
tophan (VEGQW) sequence within the carbohydrate recognition
domain (CRD) of Mincle (Yamasaki et al., 2008). We therefore
searched for any protein(s) carrying this sequence in silico. The
alignment of the primary amino acid sequence on the murine
protein database identified four individual proteins that contain
a VEGQW sequence (Figure 2A, left). Among them, only Clec4d
(also called MCL) possessed a transmembrane region and was
also strongly expressed in the lungs (Figure 2A, right; Balch
et al., 1998; Simonsen et al., 2004). MCL is a type II transmem-
brane protein that shares high homology with Mincle and pos-1052 Immunity 38, 1050–1062, May 23, 2013 ª2013 Elsevier Inc.sesses a VEGQW sequence within its CRD (Figures 2B and
S2N). As expected, 1B6 cross-reacted with a MCL-Ig fusion
protein as assessed by an in vitro binding assay (Figure 2C). We
further examined whether MCL was capable of recognizing
TDM. Soluble MCL protein could bind to plate-coated TDM and
synthetic analog trehalose dibehenate (TDB), indicating that
MCL recognized cord factor directly (Figures 2D, S2A, S2B, and
S2K–S2M). These results suggest that MCL is a TDM receptor.
We then examined the expression of MCL in myeloid cells.
A large amount of MCL, but not Mincle, was constitutively
expressed in bone-marrow-derived macrophages (BMDMs)
and BMDCs (Figures 2E, S2C, and S2D). The expression of
MCL was not limited to bone-marrow-derived cells, as shown
by the fact that freshly isolated DC subsets, tissuemacrophages,
and neutrophils but not T cells abundantly expressed MCL in the
steady state (Figures S2E–S2J; Graham et al., 2012).
We next investigated the gene induction of MCL upon expo-
sure to TDM stimuli. The expression of Mincle mRNA was
dramatically induced in BMDCs, whereas MCL mRNA was ex-
pressed even in the resting state and was only slightly induced
upon stimulation (Figure 2F). We also confirmed this at the
protein expression level, because Mincle, but not MCL, was up-
regulated upon stimulation (Figure 2G). Therefore, the regulation
of the gene expression of these two receptors differ substan-
tially, i.e., MCL is constitutive, whereas Mincle is inducible.
MCL Is an FcRg-Coupled Receptor
Mincle is known to be an FcRg-coupled receptor (Yamasaki
et al., 2008). We therefore investigated whether MCL was
associated with FcRg, although we initially thought this was un-
likely, because MCL does not possess any of the charged resi-
dues that mediate the interaction with FcRg in many other recep-
tors (Robinson et al., 2006), includingMincle. However,MCLwas
Immunity
MCL Is an FcRg-Coupled TDM Receptorfound to be expressed on the cell surface only in the presence of
FcRg, suggesting that MCL also forms a complex with FcRg
(Figure 3A). The binding seemed to be selective for FcRg,
because other signaling subunits, such as DAP10 or DAP12,
did not have any impact on the surface expression of MCL (Fig-
ure 3A). Indeed, MCL was coimmunoprecipitated with the FcRg
chain in an ectopic expression system (Figure 3B). Importantly,
the association between endogenous MCL and FcRg was also
evident in a DC line (data not shown) and BMDCs (Figure 3C).
Taken together, the requirement for FcRg demonstrated in Fig-
ure 1F may be explained by the fact that it is a subunit of MCL.
Instead of a positively charged residue within the transmem-
brane region, MCL uniquely possesses a hydrophilic threonine
(T38) at the corresponding position of the charged arginine
(R42) in Mincle. We therefore examined the contribution of T38
to the binding to FcRg by introducing a mutation in this residue.
Substitution of T38 with a hydrophobic amino acid (T38L) abol-
ished the binding with FcRg, whereas the replacement with
a hydrophilic residue (T38S) preserved the binding capacity
(Figure 3D). These results suggest that the hydrophilicity of this
position may play a role in the binding to FcRg. The hydrophilic
residue (threonine or serine) at this location is found in other
mammalian species.
MCL Is an Activating Receptor for TDM
We next analyzed whether MCL is capable of transducing
signals through FcRg. Flag-tagged MCL was introduced into
reporter cells expressing FcRg (Yamasaki et al., 2008). Upon
stimulation by plate-coated Flag antibody, MCL activated
a nuclear factor of activated T cells (NFAT)-GFP reporter as
potently as did Mincle (Figure 3E). Thus, MCL functions as an
FcRg-coupled activating receptor.
We also stimulated these cells with TDM and found that TDM
activated the NFAT reporter through MCL (Figure 3F). In line with
the findings shown in Figure 2D, the ligand recognition of MCL
seemed to beweaker than that ofMincle (Figure 3F). Importantly,
human MCL also recognized TDM (Figure S3).
We further confirmed the reactivity of 1B6 mAb against MCL
by using these transfectants. A Flag antibody was used to verify
that Mincle-Flag and MCL-Flag were expressed at comparable
intensities (Figure 3G, anti-Flag). MCL could indeed be recog-
nized by the bispecific mAb 1B6, albeit with weaker potency
compared to Mincle (Figure 3G, 1B6). In sharp contrast, each
specific antibody recognized either Mincle or MCL alone
(Figure 3G, bottom). The introduction of a mutation within the
VEGQW sequence of MCL (MCLDVEGQW) abolished the binding
of 1B6, indicating that 1B6 cross-reacted with MCL through an
identical epitope that was present in Mincle (data not shown)
(Yamasaki et al., 2008).
The 1B6 antibody blocked MCL-TDM binding even more
potently than it did against Mincle-TDM interaction, probably
because MCL bound to TDM weakly (Figure 3H). These results
suggest that the blocking effect of 1B6 in Mincle-deficient
mice demonstrated in Figure 1G was probably due to the
neutralization of MCL.
Defective Innate Immunity in MCL-Deficient Mice
To gain a better understanding of the physiological significance
of MCL, we established MCL-deficient mice (Figures S4A–S4C).Clec4d/– mice were born according to the Mendelian law and
showed no obvious abnormalities, and the cellularity of their
thymus, spleen, lymph node, and lung were not altered (data
not shown).
In order to compare the TDM responses in vitro, BMDCs and
BMDMs were prepared from WT, Clec4d/–, Clec4e/–, and
Fcer1g/– mice. The TDM-induced cytokine production was
totally dependent on Mincle and its signaling subunit, FcRg, as
previously reported (Figures 4A and 4B; Ishikawa et al., 2009;
Schoenen et al., 2010). The production of these cytokines was
still severely impaired in Clec4d/– cells (Figures 4A and 4B).
We next examined the in vivo innate immune responses.
A single injection of TDM into mice caused lethal systemic
inflammation, whereas Clec4d/– and Clec4e/– mice were,
respectively, partially and completely resistant (Figure 4C).
TDM-induced thymic atrophy was also dependent on MCL (Fig-
ure S4D), as it is on Mincle (Ishikawa et al., 2009). TDM caused
lung inflammation, including an increase in lung weight index
and granuloma formation, which were significantly suppressed
in Clec4d/– mice (Figures 4D and 4E). This was also true for
cytokine mRNA expression in the lungs (Figure 4F). Therefore,
MCL is still required for TDM-mediated innate immunity, even
though Mincle is essential for such immunity.
MCL Drives Mincle Expression
We next tried to determine why these two receptors are individ-
ually required for the innate immune responses. Two possible
explanations are as follows: (1) Mincle and MCL may synergisti-
cally operate for downstream signaling or (2) some hierarchical
relationship may exist between Mincle and MCL, e.g., MCL
regulates Mincle expression. To address the first idea, Mincle
and MCL were coexpressed in reporter cells to see whether
these two receptors synergistically augment downstream
signaling (Figure 5A). However, we detected no synergy between
Mincle and MCL in this system (Figure 5B).
Given thatMCL is constitutively expressed prior to the upregu-
lation of Mincle (Figures 2E and 2G), MCLmight play a role in the
induction of Mincle in response to TDM, as suggested in Fig-
ure 1E. We therefore examined the Mincle upregulation in the
presence and absence of MCL. The Mincle protein was induced
upon TDM stimulation in WT cells, whereas it was severely sup-
pressed in Clec4d/– cells (Figure 5C). This was also true for the
mRNA, as shown by the fact that Mincle induction was impaired
in Clec4d/– cells (Figure 5D, left). Slight induction of Mincle in
Clec4d/– mice was probably due to signaling through low
amount of Mincle itself (Figure S5). In contrast, Mincle was
dispensable for MCL expression (Figure 5D, right). Furthermore,
Mincle induction upon TDM injection in vivo was also compro-
mised in Clec4d/– mice (Figure 5E).
Defective responses in Clec4d/– DCs were restored by re-
constituting the cells with exogenous Mincle (Figures 5F and
5G). Based on the above findings, we conclude that MCL is crit-
ically involved in TDM-mediated innate immune responses by
driving Mincle expression.
MCL Promotes DC Maturation to Prime T Cells
We then asked whether Mincle and MCL contribute to T cell
priming in vitro, because TDM has been known as a potent
adjuvant (Numata et al., 1985; Sakurai et al., 1989; WerninghausImmunity 38, 1050–1062, May 23, 2013 ª2013 Elsevier Inc. 1053
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Figure 3. MCL Is an FcRg-Coupled TDM Receptor
(A) FcRg-dependent surface expression of MCL. HEK293T cells were transfected with HA-tagged MCL together with pMX-IRES-GFP vector alone (–), FcRg,
DAP10, or DAP12. Surface expression of MCL was detected by mAb against HA, which is attached at the extracellular region (C terminus) of MCL.
(B) MCL is associated with FcRg. HEK293T cells were transfected with HA-tagged-MCL or -Mincle together with FcRg. Lysates were immunoprecipitated with
HA antibody and blotted with FcRg antibody and HA antibody. Total lysates were also blotted with FcRg antibody.
(C) EndogenousMCL is bound to FcRg. Lysates from 13 107 cells of BMDCs were immunoprecipitated with mouse IgG or MCL antibody (66-1) and blotted with
FcRg antibody and MCL antibody (1K1-41).
(legend continued on next page)
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MCL Is an FcRg-Coupled TDM Receptoret al., 2009). BMDCs were pulsed with the ovalbumin (OVA)
antigen and cocultured with T cells from OVA-specific T cell
receptor (TCR) transgenic (Tg) mice in the absence or presence
of TDM. TDM enhanced the antigen-specific secretion of
interferon-g (IFN-g) and interleukin-17 (IL-17) from CD4+ OT-II
T cells without affecting their proliferation (Figure 6A). However,
the enhancement was severely suppressed in the absence of
MCL, Mincle, and their common subunit FcRg chain. Thus,
MCL and Mincle can promote the development of T helper 1
(Th1) and Th17 cells (Schoenen et al., 2010).
This was also true for IFN-g production from CD8+ OT-I
T cells (Figure 6B). In addition, both receptors were required
for CD8+ T cell activation when a whole antigen was presented
on major histocompatibility complex (MHC) class I molecules
through cross-presentation (Figure 6C). These results sug-
gest that Mincle and MCL play a crucial role in T cell priming
through DCs.
To investigate how the Mincle and MCL expressed on DCs
support T cell priming, we examined the expression of costimu-
latory molecules on DCs. TDM induced the upregulation
of CD80, CD86, and CD40 in WT DCs (Figure 6D). However,
this induction was suppressed in Clec4d/–, Clec4e/–, and
Fcer1g/– DCs.
TDM upregulated chemokine receptor CCR7 on BMDCs,
as assessed by CCL19-Fc binding, in a MCL- and Mincle-
dependent manner (Figure 6D). Subcutaneous administration
of TDM alone increased the number of CD11c+ DCs in the drain-
ing lymph nodes, whereas this was compromised in Clec4d/–
and Clec4e/– mice (Figure 6E). These results suggest that
TDM induces the maturation and migration of DCs, and both
Mincle and MCL contribute to these responses. MCL-mediated
adjuvanticity was also verified by human MCL (Figure S6).
Defective Acquired Immunity in MCL-Deficient Mice
We then examined acquired immune responses in vivo. The
immunization of mice with OVA antigen together with TDM
greatly promoted footpad swelling, a typical delayed type
hypersensitivity (DTH) response, upon secondary challenge
with the antigen alone (Figure S7A). The TDM-induced DTH re-
sponses were significantly impaired in Clec4e/– and Clec4d/–
mice (Figure 7A). This impairment was specific for TDM, as
shown by the fact that footpad swelling elicited by the yeast
adjuvant zymosan was not altered between the mice (Fig-
ure S7B). These results suggest that MCL and Mincle both
mediate the adjuvant activity of TDM toward DTH responses.
TDM augmented the production of OVA-specific IgG in WT
mice during the same immunization protocol. However, this
effect was impaired in Clec4e/– mice and was partially
reduced in Clec4d/– mice (Figure 7B).(D) Mutagenesis analysis of transmembrane region in MCL. HEK293T cells were t
with FcRg. Lysates were immunoprecipitated with HA antibody and blotted wit
antibody.
(E) MCL transduces activation signal through FcRg. NFAT-GFP reporter cells wer
stimulated with plate-coated Flag antibody for 24 hr. Induction of NFAT-GFP wa
(F) TDM signals through MCL-FcRg axis. Reporter cells were stimulated with pla
(G) 1B6 recognizes MCL. 2B4 cells expressing FcRg alone or together with Fla
(1B6 and 4A9), and MCL antibody (1K2-5). Open histograms show staining with
(H) 1B6 blocks TDM recognition by MCL. Mincle or MCL reporter cells were trea
Data are presented as mean ± SD (E, F, H) and are representative of two (C) or tFinally, we performed a murine model of Th17-cell-mediated
autoimmune disease, experimental autoimmune encephalomy-
elitis (EAE). WT mice were immunized with myelin oligodendro-
cyte glycoprotein (MOG) peptide together with various adju-
vants. TDM, but not incomplete Freund’s adjuvant (IFA) alone,
was capable of eliciting EAE (Figure S7C). This was almost totally
abrogated inClec4d/– mice, whereas only partial reduction was
observed in Clec4e/– mice (Figures 7C and 7D). Simulta-
neously, skin inflammation was observed at the injection sites
of the same immunized WT mice (Martinez de la Torre et al.,
2005). This pathology seemed to reflect an innate immune
response, because it was induced by TDM even in Rag1/–
mice (Figure S7D). In sharp contrast to the EAE, the skin inflam-
mation was completely abolished in Clec4e/– but not in
Clec4d/– mice (Figure 7E). Thus, Mincle and MCL differentially
contribute to innate inflammation and T cell-dependent EAE,
respectively. Indeed, splenocytes from Clec4e/– and Clec4d/–
mice had lower IL-17 expression in the recall responses against
ex vivo stimulation with MOG peptide (Figure 7F).
These results suggest that MCL critically contributes to
acquired immunity, particularly to EAE development. Mincle
induction might be impaired in Clec4d/– mice during acquired
immunity, but the contribution of MCL to EAE was clearly Mincle
independent (Figures 7C and 7D).
MCL and Mincle Contribute to Mycobacterial Infection
We finally examined the contribution of MCL and Mincle to
mycobacterial infection in vitro. The induction of tumor necrosis
factor (TNF) and MIP-2 mRNA upon M. tuberculosis H37Rv
infection was significantly impaired in Clec4d/– and Clec4e/–
BMDMs (Figure 7G). Mycobacteria-induced Mincle induction
was also severely impaired in Clec4d/– BMDMs (Figure 7H).
WT, Clec4d/–, and Clec4e/– mice were infected with
Mycobacterium bovis Bacille de Calmette et Gue´rin (BCG) and
we examined host immune responses against mycobacteria.
The IFN-g production in response to PPD was partially impaired
in the Clec4d/– and Clec4e/– mice (Figure 7I).
These results suggest that MCL and Mincle contribute to the
immune responses against mycobacteria.
DISCUSSION
In this study, we showed that the C-type lectin MCL is an
FcRg-coupled activating receptor for a mycobacterial adjuvant,
TDM. In support of this finding, a recent study reported that
MCL functions as an activating receptor (Graham et al., 2012).
The acquisition of different receptors with distinct functions,
but that share the same ligand, would allow the host to more
finely regulate the immune responses.ransfected with HA-taggedMCL (WT) or mutant MCL (T38L and T38S) together
h FcRg antibody. Total lysates were also blotted with HA antibody and FcRg
e transfected with FcRg together with Flag-tagged-Mincle or -MCL. Cells were
s analyzed by flow cytometry.
te-coated TDM for 24 hr.
g-tagged-Mincle or -MCL were stained with Flag antibody, Mincle antibody
isotype control.
ted with 1B6 or rat IgG, followed by stimulation with TDM (1 mg/well).
hree (A, B, D–H) separate experiments. See also Figure S3.
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Figure 4. Impaired Innate Immune Responses in Clec4d–/– Mice
(A and B) TDM-induced cytokine production in vitro. BMDCs (A) and BMDMs (B) fromWT, Clec4d/–, Clec4e/–, and Fcer1g/– mice were stimulated with plate-
coated TDM or zymosan (100 mg/ml) for 48 hr. Concentrations of MIP-2 and TNF were determined by ELISA. Data are presented as mean ± SD and are
representative of three separate experiments.
(C) Lethal systemic inflammation by TDM. Survival curve of WT (n = 33), Clec4d/– (n = 11), Clec4e/– (n = 10), and Fcer1g/– (n = 10) mice after intravenous
administration of oil-in-water emulsion of TDM.
(D) TDM-induced lung swelling. At day 7 after injection of TDM or vehicle alone (veh.), lung swelling was evaluated by lung weight index (LWI).
(E) TDM-induced granuloma formation. Histology of lungs was examined by HE staining at day 7 after TDM injection. Scale bars represent 0.1 mm. Area of the
granulomas was calculated as ratio of granuloma area/total lung area and shown in right.
(F) TDM-induced proinflammatorymediators.mRNA expression of TNF, IL-1b, MIP-2, andMIP-1a in the lungs at day 7 after TDM injection were evaluated by real-
time PCR. *p < 0.05; **p < 0.01.
See also Figure S4.
Immunity
MCL Is an FcRg-Coupled TDM Receptor
1056 Immunity 38, 1050–1062, May 23, 2013 ª2013 Elsevier Inc.
0.0 
0.1 
0.2 
0.3 
0.4 
0.5 
0.0 
0.0 
0.0 
0.1 
0.1 
0.1 
0.1 
Anti-Mincle
TDM (hr) 0 6 12 24 0 6 12 24 0 6 12 24
WT Clec4d–/–
D
WT
Clec4d–/–
Clec4d–/–
0 10 100
TDM (ng/well)
1
0.0
0.5
0.4
0.3
0.2
0.1
M
in
cl
e 
m
R
N
A 
(re
lat
ive
)
0 10 100
TDM (ng/well)
1
0.12
0.10
0.08
0.06
0.04
0. 2
0. 0
WT
Clec4d–/–
Clec4e–/–
MCL
Mincle
MCL + Mincle
M
CL
 
m
R
N
A 
(re
lat
ive
)
Anti-actin
0 
20 
40 
60 
80 
0 
20 
40 
60 
80 
1 2 3 4 0
N
FA
T-
G
FP
 
(%
)
80
60
40
20
0
1 10 100
TDM (ng/well)
A
Anti-Flag
Anti-HA
Mincle-Flag – +
MCL-HA + –
+
+
B C
G
E
0.0 
0.2 
0.4 
0.6 
0.8 
1.0 
1.2 
D0 D1 D3 D7 
0.0
1.2
1.0
0.8
0.6
0.4
0.2
0 1 3 7
WT
Clec4d–/–
M
in
cl
e 
m
R
N
A 
(re
lat
ive
)
Anti-actin
Anti-Mincle
WT
TDM (d) 0 1 3 7
Clec4d /
0 1 3 7
TDM (d)
!"
#!$!!!"
%!$!!!"
&!$!!!"
!" #" #!" #!!"
!"
%$!!!"
'$!!!"
($!!!"
)$!!!"
#!$!!!"
#%$!!!"
!" #" #!" #!!"0 10 100
TDM (ng/well)
1
TN
F 
(ng
/m
l) 10
12
0 10 100
TDM (ng/well)
1
0
M
IP
-2
 (n
g/m
l) 30
10
20 8
6
4
2
0
F
TDM – +
Clec4d /
– + – +
Mincle
WT
Anti-actin
Anti-Mincle
+ Mock
+ Mock
+ Mincle
Mock Mock
Clec4e–/–
Figure 5. MCL Drives Inducible Expression of Mincle by TDM
(A and B) Coexpression of MCL andMincle. Reporter cells were transfectedwith HA-taggedMCL and/or Flag-taggedMincle (A). These cells were stimulated with
TDM, HA antibody, and Flag antibody for 24 hr and GFP expression was determined (B).
(C) Immunoblotting of Mincle in BMDCs. BMDCs from WT, Clec4d/–, and Clec4e/– mice were stimulated with TDM for indicated times. Lysates were blotted
with Mincle antibody and actin antibody.
(D) mRNA expression of Mincle andMCL in BMDCs. BMDCswere stimulated with TDM for 6 hr. mRNA expression of Mincle andMCLwasmeasured by RT-PCR.
(E) Mincle induction in lungs. WT andClec4d/– mice were injected with TDM and lungs were obtained at indicated days after injection. Immunoblotting of Mincle
and actin (left). mRNA expression of Mincle was shown (right).
(F and G) Restoration ofClec4d/– DC function by exogenous Mincle. BMDCswere transducedwithMincle through lentivirus vector, followed by stimulation with
TDM. Lysates were blotted with Mincle antibody and actin antibody (F). Concentrations of MIP-2 and TNF were determined by ELISA (G).
Data are presented as mean ± SD (B, D, E, G) and are representative of two separate experiments. See also Figure S5.
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MCL Is an FcRg-Coupled TDM ReceptorThe in vitro and in vivo innate immune responses induced
by TDM were almost completely abrogated in Mincle-deficient
mice (Ishikawa et al., 2009; Schoenen et al., 2010), indicating
that MCL cannot substitute for Mincle. Therefore, we did not
initially expect that MCL deficiency would influence the
TDM-mediated innate immune responses. However, MCL
was crucial for these responses, presumably by initiating
ligand-mediated Mincle induction, as follows. (1) MCL is a
dominant TDM receptor at the resting stage. (2) TDM binds
to MCL to initiate Mincle expression, probably through C/
EBPb (Matsumoto et al., 1999), and (3) TDM binds to MCL
and Mincle, which efficiently induce Mincle expression. (4)
TDM binds to a sufficient amount of high-affinity receptor
Mincle and delivers signals that might be strong enough to
induce innate immune responses. MCL-intrinsic signaling
capacity was also verified by anti-MCL-mediated crosslinking
in WT cells.Although the coexpression of Mincle and MCL did not show a
synergistic effect, at least in the reporter cell line, some physical
or functional interaction might be operating in the context of
myeloid cells. The possibility of heterophilic oligomerization
between Mincle and MCL cannot be excluded, as occurs with
the NKG2-CD94 and Dectin-1-Galectin-3 dimers (Esteban
et al., 2011; Sullivan et al., 2007). Therefore, the cooperation
between Mincle and MCL is still an intriguing issue that needs
to be clarified.
In contrast to innate immune responses, TDM-induced EAE
was quite different, namely the symptom was only partially sup-
pressed in Clec4e/– mice, although MCL was indispensable
for EAE. Thus, MCL is capable of mediating such acquired
immunity independent of Mincle. The precise molecular mecha-
nisms by which MCL predominantly contributes to EAE are
currently unclear. Resistance to EAE in Clec4d/– mice was not
due to the mixed genetic background; a similar contrast wasImmunity 38, 1050–1062, May 23, 2013 ª2013 Elsevier Inc. 1057
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Figure 6. Impaired APC Functions in Clec4d–/– DCs
(A) TDM-enhanced CD4+ T cell function. BMDCs from WT, Clec4d/–, Clec4e/–, and Fcer1g/– mice were left untreated (open circles) or stimulated with plate-
coated TDM (closed circles) and then cocultured with CFSE-labeled OT-II cells and OVA323-339 peptide for 2 days. Concentrations of IFN-g and IL-17 were
measured by ELISA. Cell proliferation was evaluated by CFSE dilution.
(B and C) TDM-enhanced CD8+ T cell function. TDM-stimulated BMDCswere cocultured with CFSE-labeled OT-I cells and OVA257-264 peptide (B) or OVA protein
(C) for 2 days.
(D) Upregulation of costimulatory molecules by TDM. BMDCswere left untreated or stimulated with TDM for 48 hr. Surface expression of CD80, CD86, CD40, and
CCR7 was analyzed as indicated.
(E) TDM-induced DC accumulation in draining LNs. Mice were injected with oil-in-water emulsion of TDM at the base of the tail. Inguinal LNs were collected at
7 days after TDM injection. The number of CD11c+ cells was analyzed by flow cytometry. *p < 0.05, **p < 0.01.
Data are presented as mean ± SD (A–C) and are representative of three (A–D) separate experiments. See also Figure S6.
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MCL Is an FcRg-Coupled TDM Receptoralso evident whenClec4d/– micewere comparedwith littermate
Clec4d+/+mice (data not shown). Thus far, we have not found any
MCL-specific APC functions, at least in BMDCs. MCL, but not
Mincle, is reported to be an endocytotic receptor (Arce et al.,1058 Immunity 38, 1050–1062, May 23, 2013 ª2013 Elsevier Inc.2004), so it is possible that MCL may uniquely promote antigen
processing or trafficking in some particular DC subsets, as was
reported for Clec9a (Sancho et al., 2009). Alternatively, it is
tempting to speculate that gd T cells expressing MCL and FcRg
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Figure 7. Critical Role of MCL in Acquired Immune Responses
(A) TDM-induced DTH response. Mice were immunized with OVA in oil-in-water emulsion of TDM, followed by injection of OVA into footpads at 7 days after
immunization. Footpad thickness was measured at 24 hr after challenge. Each symbol represents an individual mouse.
(B) Antigen-specific antibody production. Serumwas collected at 5 days after OVA challenge as described in (A). Concentration of anti-OVA IgG was determined
by ELISA. Naive (n = 7), WT (n = 12), Clec4d/– (n = 8), Clec4e/– (n = 10), and Fcer1g/– (n = 10) mice were used in this experiment.
(C and D) TDM-induced EAE. WT (n = 20), Clec4d/– (n = 9), and Clec4e/– (n = 20) mice were immunized with MOG35-55 peptide in IFA containing TDM. The
disease severity of each mouse was scored, and the mean clinical score (C) and disease incidence (D) at the indicated times were plotted.
(E) TDM-induced skin inflammation. The incidence of skin inflammation at the immunization site of EAE-treated mice was shown. See also Figure S7D.
(F) Recall response against MOGantigen.Mice were rechallengedwithMOG35–55 peptide and pertussis toxin at 20 days after immunization for EAE. Spleenswere
collected at 4 days after rechallenge and stimulated with MOG35–55 peptide for 96 hr. Concentrations of IL-17 were determined by ELISA. Data are representative
of two separate experiments. WT (n = 7), Clec4d/– (n = 7), and Clec4e/– (n = 7) mice were used in total.
(G and H) Mycobacterial infection in vitro. BMDMswere infected withM. tuberculosisH37Rv, and mRNA expressions of TNF, MIP-2 (G), and Mincle (H, left) 24 hr
after infection were determined by RT-PCR. Immunoblotting of Mincle and actin is shown (H, right).
(I) WT, Clec4d/–, and Clec4e/– mice (n = 5 for each) were intratracheally infected with M. bovis BCG. Spleens were obtained 3 weeks after infection and
stimulated with PPD for 4 days and concentration of IFN-g in the supernatants was determined by ELISA for individual mice.
Data are presented as mean ± SEM (B, F, I) or SD (G, H). *p < 0.05; **p < 0.01. See also Figure S7.
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Immunity
MCL Is an FcRg-Coupled TDM Receptormay produce IL-17 in response to TDM in a TCR-independent
manner (Martin et al., 2009). One might argue that MCL may
contribute to the fundamental process of EAE development,
rather than as a TDM receptor. However, this is unlikely because
the Clec4d/– mice developed EAE when we used an adjuvant
that contains TLR ligands (data not shown).
The important question is what determines the functional
difference between Mincle and MCL. Interestingly, the recogni-
tion of TDMbyMCLappearedweaker than that byMincle.Mincle
possesses a conserved glutamic acid-proline-asparagine (EPN)
sequence within its CRD (Drickamer, 1992). This EPN motif is
critical for TDM recognition by Mincle (Ishikawa et al., 2009),
but this motif was not conserved in MCL. These results imply
that the low ligand affinity may be advantageous for MCL, pre-
sumably to limit the robustness of innate immune responses.
On the contrary, constitutive MCLmay deliver sustained signals,
which may compensate for the signal intensity required for ac-
quired immunity. Extensive comparisons of the affinity, stoichi-
ometry, and signaling kinetics between Mincle and MCL may
clarify a differential role for the two CLRs. Indeed, we have previ-
ously reported that the quantity and duration of FcRg signals
could lead to distinct immune responses (Yamasaki et al., 2004).
Alternatively, the functional difference between the two recep-
tors may be solely attributable to their distributions or expression
modes such as inducible versus constitutive. To dissect which of
the ‘‘structural characteristics’’ or ‘‘expression patterns’’ deter-
mines the distinct function of these two CLRs, it would be
intriguing to establish genetically targeted mice expressing
Mincle instead of MCL, and vice versa.
Currently, the structural basis for the interaction of MCL to
FcRg through the hydrophilic residue remains unclear. This
interaction may vary depending on the cell context (Graham
et al., 2012). Recently, several receptors were reported to be
associated with FcRg or DAP12 despite their lack of a positively
charged residue within their transmembrane region (Enomoto
et al., 2010;Wines et al., 2006). Accumulating evidence of various
modes of association with ITAM-bearing adaptors may expand
the pool of candidate for potential ITAM-coupled receptors.
Mincle and some other C-type lectins recognize damage-
associated molecular patterns (DAMPs) (Ahrens et al., 2012;
Cambi and Figdor, 2009; Oka et al., 1998; Sancho et al., 2009;
Yamasaki et al., 2008; Zhang et al., 2012). MCL might also
function as a receptor for endogenous ligands, although we
have not observed any evidence of this so far. The CLR family
has a large number of members, and each of them has broad
ligand specificity compared with that of TLRs, NLRs, and
RLRs. These characteristics of CLRs may enable the host to
recognize a wide variety of molecular patterns associated with
pathogens and damaged self.
Recent developments in genomic sequencing of many spe-
cies have shown that Mincle and MCL are not only homologous
to each other, but are also highly conserved between species.
Genomic annotation of the Mincle loci of various mammalian
species revealed that monotremes and marsupialia possess
onlyMincle, but notMCL. However, placental mammals possess
both Mincle and MCL, and they are located next to each other
in the genome, thus suggesting that MCL may arise from the
gene duplication of Mincle. Marsupialia have immature acquired
immunity, particularly in neonates, compared with placentalia1060 Immunity 38, 1050–1062, May 23, 2013 ª2013 Elsevier Inc.(Edwards et al., 2012). It is therefore speculated that MCL may
have evolved along with the development of acquired immunity.
The significance of MCL is verified by the fact that this gene is
conserved among placental mammals.
It can be speculated that Mincle and MCL cooperatively func-
tion during the host defense against mycobacterial infection
through distinct immune responses. Given that high mycobacte-
rial loads in Mincle-deficient mice have recently been reported
(Behler et al., 2012; Lee et al., 2012), a deficiency in antimyco-
bacterial responses might be observed to be even more severe
in Mincle-MCL double-deficient mice. Because the genes
encoding Mincle and MCL are located within 30 kilobases of
each other on mouse chromosome 6, double-deficient mice
have to be generated by sequential targeting of these two genes
in the same ES cell line, which is now under development.
It was reported that cationic liposome formulated with syn-
thetic cord factor TDB, CAF01, has been developed as an
adjuvant that potentially primes T cell responses in mice and
humans (Aagaard et al., 2011; Agger et al., 2008; Christensen
et al., 2009; Lindenstrøm et al., 2009). We confirmed that MCL,
as well as Mincle, recognizes synthetic TDB (Ishikawa et al.,
2009; Schoenen et al., 2010), suggesting that MCL may also
be involved inmediating the adjuvant effect of the CAF01. Impor-
tantly, human MCL is also capable of activating acquired
immune responses.
Although TDM is known as a potent adjuvant, some adverse
effects, such as local inflammation and granulomagenesis, have
been reported (Bekierkunst, 1968; Fomsgaard et al., 2011). It
has been demonstrated that a synthetic TDM analog, 6,60-Di-
deoxy-6,60-bis-mycolylamino-a,a-trehalose (TDNM) or trehalose
6,60-dicorynomycolate (TDCM) are less toxic, although they still
potently activated antitumor activity (Sakurai et al., 1989; Wata-
nabe et al., 1999). These observations may now be explained
by the binding specificity of these analogs toward the two recep-
tors. Less toxic adjuvants, such as TDNM or TDCM, may prefer-
entially bind to MCL. It would be still possible that MCL may
also recognize some unknown ligands in other pathogens.
Our identification of two TDM receptors with potentially
distinct functions will provide information for the development
of innovative adjuvants for vaccines. For instance, a synthetic
ligand specific for MCL rather than Mincle may selectively
enhance the cellular immunity while inducing minimal adverse
effects derived from innate immune responses, which are largely
dependent on Mincle (Ishikawa et al., 2009).
EXPERIMENTAL PROCEDURES
Mice
Clec4e/ mice were generated previously (Yamasaki et al., 2009) and back-
crossed at least eight generations with C57BL/6 mice. Fcer1g/ mice of
C57BL/6 genetic background were provided by T. Saito (RIKEN, Japan) (Park
et al., 1998). Clec4d/ and Clec4egfp/gfp mice were established with E14.1
(129P2) embryonic stem cells and used as C57BL/6 and 129 mixed genetic
background.C57BL/6micewereobtained fromJapanClea.Allmiceweremain-
tained in a filtrated-air laminar-flow enclosure and given standard laboratory
food and water ad libitum. Animal protocols were approved by the committee
ofEthics onAnimalExperiment, Faculty ofMedical Sciences,KyushuUniversity.
Homogeneous Proximity Assays
The binding of Ig-fusion proteins and 1B6 was determined by amplified lumi-
nescent proximity homogeneous assay according to the manufacturer’s
Immunity
MCL Is an FcRg-Coupled TDM Receptorrecommendation (AlphaLISA, PerkinElmer). In brief, Ig-fusion proteins and
biotinylated 1B6 (3 mg/ml) were incubated with anti-hIgG acceptor beads
and streptavidin-coated donor beads. Oxygen-based energy transfer was
detected by light production at 615 nm (EnSpire, PerkinElmer) and presented
as relative light units (RLU).
Ig-Fusion Proteins
MCL-Ig and Mincle-Ig fusion proteins were prepared as described previously
(Yamasaki et al., 2008). In brief, the C terminus of the extracellular domain of
murine MCL (77–219 aa) or murine Mincle (46–214 aa) was fused to the
N terminus of hIgG1 Fc region (mMCL-Ig and mMincle-Ig, respectively). The
C terminus of the extracellular domain of human MCL (42–215 aa) or human
Mincle (46–219 aa) was fused to the N terminus of hIgG1 Fc region (hMCL-
Ig and hMincle-Ig, respectively). Ig-fusion proteins were incubated with
0.2 mg/well of plate-coated TDM, and bound proteins were detected by using
HRP-labeled anti-human IgG. CCL19-Fc (14-1972-63) was purchased from
eBioscience.
Granuloma Formation
TDM was prepared as oil-in-water emulsion consisting of mineral oil (9%),
Tween-80 (1%), and PBS (90%) as previously described (Numata et al.,
1985). 150 ml of emulsion containing 150 mg of TDMwas injected intravenously
into mice. Lungs were removed at 7 days after TDM injection and fixed in 10%
formaldehyde for hematoxylin-eosin staining. Lung weight index was calcu-
lated as previously described (Ishikawa et al., 2009). A part of lungs were
frozen for RNA analysis. The area of granuloma was quantified by ImageJ
software.
Experimental Autoimmune Encephalomyelitis
Female mice were immunized by subcutaneous administration with 200 mg
of MOG35–55 peptide (Invitrogen) emulsified in IFA (Difco) containing 500 mg
of TDM on day 0, supplemented with intravenous injection of 200 ng of
pertussis toxin (List Biological Laboratories). Mice received an additional
intraperitoneal injection of 200 ng pertussis toxin on day 2. Disease severity
was scored as described previously (Miyake et al., 2007). For in vitro restimu-
lation analysis, mice were injected intraperitoneally with 50 mg of MOG35–55
peptide and 200 ng of pertussis toxin on day 20. Spleens were collected on
day 24 and stimulated with MOG35–55 peptide for 4 days. Concentrations of
IL-17 in culture supernatants were determined by ELISA.
Delayed-type Hypersensitivity
Mice were sensitized by subcutaneous injection of 200 mg of OVA in oil-in-
water emulsion of TDM (100 mg). At 7 days after sensitization, mice were
challenged with 200 mg of heat-aggregated OVA (70C, 1 hr) in 20 ml of PBS
into both footpads. Footpad swelling was measured with vernier caliper and
calculated as (footpad thickness after challenge)  (footpad thickness before
challenge). Serum anti-OVA IgG was determined at day 5 after challenge by
ELISA with anti-OVA IgG1 (2D11, Abcam) as a standard.
Mycobacterial Infection
For in vitro infection model, BMDMs were infected withM. tuberculosisH37Rv
at a multiplicity of infection (MOI) of 1.0, and mRNA or lysates were prepared
24 hr after infection. For the in vivo infection model, the mice were infected in-
tratracheally with 2 3 105 CFU of M. bovis BCG. Three weeks after infection,
single-cell suspensions of splenocytes (5 3 105 cells) were stimulated with
PPD (Japan BCG Laboratory) for 4 days, and the concentration of IFN-g in
culture supernatants was determined by ELISA.
Statistics
An unpaired two-tailed Student’s t test was used for all the statistical analyses.
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